Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 648.95
-10.80 (-1.64%)
At close: Oct 1, 2026
NSE:NEPHROPLUS Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 10,528 | 9,988 | 7,558 | 5,662 | 4,373 | 3,169 |
Revenue Growth | 39.30% | 32.16% | 33.50% | 29.47% | 37.99% | 11.40% |
Gross Profit Gross Profit Growth | 4,082 | 3,794 | 2,673 | 1,832 | 1,142 | 1,290 |
Operating Income Operating Income Growth | 1,501 | 1,388 | 956.04 | 476.58 | 17.16 | -186.26 |
Net Income Net Income Growth | 851.1 | 768.4 | 670.96 | 351.33 | -117.89 | -219.75 |
Earnings Per Share EPS Growth | 8.63 | 8.10 | 8.01 | 4.40 | -1.53 | -26.51 |
EPS Growth | 7.75% | 1.12% | 82.05% | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 5,975 | 5,813 | 5,155 | 4,315 | 3,861 | 3,169 |
Philippines Philippines Growth | 3,349 | 3,112 | 1,665 | 681.21 | 343.34 | - |
Uzbekistan Uzbekistan Growth | 1,109 | 1,004 | 733.95 | 664.95 | 168.5 | - |
Others Others Growth | - | - | 3.71 | - | - | - |
Nepal Nepal Growth | - | 58.74 | - | - | - | - |
Total Total Growth | 10,528 | 9,988 | 7,558 | 5,662 | 4,373 | 3,169 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 4,256 | 4,256 | 1,884 | 782.46 | 660.53 | 1,281 |
Total Debt Total Debt Growth | 797.07 | 797.07 | 2,578 | 2,678 | 2,137 | 1,197 |
Net Cash (Debt) Net Cash Growth | 3,459 | 3,459 | -693.53 | -1,896 | -1,477 | 83.35 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 35.08 | 36.47 | -8.28 | -23.72 | -19.17 | 10.05 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 2,326 | 1,353 | 722.8 | 112.69 | 119.18 |
Capital Expenditures CapEx Growth | - | -1,189 | -997.75 | -773.49 | -715.69 | -429.7 |
Free Cash Flow Free Cash Flow Growth | - | 1,136 | 355.72 | -50.69 | -603 | -310.52 |
Free Cash Flow Growth | - | 219.47% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 38.77% | 37.98% | 35.36% | 32.36% | 26.12% | 40.70% |
Operating Margin | 14.26% | 13.90% | 12.65% | 8.42% | 0.39% | -5.88% |
Pretax Margin | 10.45% | 9.76% | 11.57% | 5.86% | -1.96% | -8.86% |
Profit Margin | 8.08% | 7.69% | 8.88% | 6.21% | -2.70% | -6.93% |
FCF Margin | - | 11.38% | 4.71% | -0.90% | -13.79% | -9.80% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 75.19 | 66.19 | - | - | - | - |
Forward PE | 37.81 | 30.31 | - | - | - | - |
P/FCF Ratio | 57.30 | 44.75 | - | - | - | - |
PS Ratio | 6.18 | 5.09 | - | - | - | - |